MedCity News

SEPTEMBER 12, 2022

These next-generation tools create more personalized experiences for patients, more information to guide clinical decision making and plenty of data for biopharma companies to use to continually improve therapies and to make a case for reimbursement.

Biopharma 98

Biopharma Medical Competition Patients 98

European Pharmaceutical Review

AUGUST 16, 2023

The National Institute for Health and Care Excellence (NICE) has also issued guidance recommending reimbursement of Pombiliti + Opfolda for use within the National Health Service (NHS) in England and Wales. Both the MHRA and NICE decisions were based on clinical data from the Phase III PROPEL study.

Marketing 84

Marketing Medicine Healthcare Healthcare 84

PM360

OCTOBER 26, 2023

Klick Health announced that admired market access professional Ellen Cappellino has joined the agency to further build out its value, access, and reimbursement capabilities and help transform the healthcare experience for patients. I was drawn to Klick’s world-class team and technological capabilities,” she explained.

Marketing 52

Marketing Healthcare Healthcare Consulting 52

European Pharmaceutical Review

SEPTEMBER 22, 2023

Eli Lily’s ulcerative colitis biologic This recommendation makes “Great Britain one of the first countries in the world to provide nationally reimbursed access; and national access should now be implemented within 30 days,” shared Laura Steele, President & General Manager, Northern Europe, Eli Lilly and Company. There were 24.2

Patients 97

Patients Medicine Pharma Management 97

Contrarian Sales Techniques

JANUARY 25, 2023

When I first started working as a pharmaceutical sales representative , I didn't fully understand the complexity of reimbursement and insurance coverage. The reimbursement and insurance systems in place can be difficult to navigate. But as I progressed in my career, I came to see just how vital it is to the job.

Insurance 52

Insurance Pharmaceutical Sales Sales Pharmaceutical 52

Legacy MEDSearch

AUGUST 16, 2023

ClarityPro is also the first and only device to offer NTAP reimbursement for the diagnosis of ESE. The NTAP reimbursement program recognizes new technologies that provide substantially improved clinical benefit over currently available therapies, giving Medicare beneficiaries timely access to advancements in healthcare.

FDA 52

FDA Food and Drug Administration Healthcare Provider Recruitment 52

Referral MD

JANUARY 8, 2024

Quality Improvement: Prioritizing the quality of healthcare services , value-based care encourages evidence-based practices and adherence to clinical guidelines, resulting in improved overall healthcare standards. By leveraging ReferralMD, healthcare organizations can effectively navigate the complexities of value-based care.

Healthcare 52

Healthcare Healthcare Healthcare Provider Management 52

pharmaphorum

NOVEMBER 2, 2022

Citeline provides intelligence, data and software for clinical trials, development and regulatory compliance and was formerly part of Informa was called Pharma Intelligence ahead of a rebranding earlier this year.

Pharma 75

Pharma Marketing Patients Consulting 75

Pharmaceutical Technology

DECEMBER 15, 2022

Post-early access/ATU, a negotiated price and reimbursement level is determined according to the clinical value rating (Service Médical Rend, SMR) and Amélioration du Service Médical Rendu (ASMR) rating, evaluated by the Transparency Commission (TC) of HAS. 53% of medicines under ATU/early access treat oncology indications.

Medicine 59

Medicine Marketing Distribution Pharmaceutical 59

Legacy MEDSearch

NOVEMBER 6, 2023

CPT codes are granted and regulated by the AMA CPT® Editorial Panel and are widely used by government payers, including Medicare and Medicaid, and commercial health plans to describe healthcare services and procedures for reimbursement. HistoSonics has offices in Ann Arbor, Michigan and Minneapolis, MN. Are you hiring?

Recruitment 52

Recruitment Physicians Medical Patients 52

Medical Device Success

JUNE 6, 2021

In this episode we examine why some technologies are adopted while others are not – even if there is clinical proof that they should be. We explore issues impacting long-term adoption in the pre-product release, product release, and post-release phases along with how people react to change.

Medical 130

Medical Physicians Education Sales 130

pharmaphorum

DECEMBER 7, 2022

The HTA body, the CT ( Commission de la Transparence – Transparency Commission), is charged with providing guidance to inform pricing negotiations in two main forms: a comparative clinical benefit rating, the ASMR ( Amélioration du Service Médical Rendu ), and a target patient population. Rare diseases: a flawed system.

Patients 86

Patients Manufacturing Consulting Marketing 86

Clarivate

JUNE 26, 2023

Specifically, data can help HTA bodies in evaluating, interpreting, and deliberating the evidence in reimbursement decision making if presented alongside the economic and clinical evidence. Health technology assessment (HTA) bodies also have some appetite for this information.

Food and Drug Administration 52

Food and Drug Administration Patients Side effects Medicine 52

World of DTC Marketing

FEBRUARY 7, 2022

There usually is an unbreakable firewall between commercial and Market Acess/Reimbursement. If they decide to continue with clinical trials, a neutral, independent third party needs to review the data. .” To me, an enormous warning flag went up when the VP of Market Access was on a call with the commercial organization (sales).

Marketing 253

Marketing Pharma Sales Management 253

European Pharmaceutical Review

DECEMBER 13, 2023

EC’s approval of the treatment was based on data from a Phase II double-blind, placebo-controlled clinical trial, PIONEER. Additional markets will follow dependent on local healthcare technology assessment and reimbursement process timelines. It was also well-tolerated with a favourable safety profile.

Medicine 64

Medicine Safety Patients Healthcare 64

Referral MD

JANUARY 19, 2024

Providers are encouraged to adopt evidence-based practices and follow clinical guidelines to ensure patients receive the most effective and appropriate care. Additionally, ReferralMD streamlines the payment and reimbursement process by ensuring that accurate coding of the patient’s health conditions is captured.

Healthcare Provider 52

Healthcare Provider Healthcare Healthcare Management 52

pharmaphorum

DECEMBER 6, 2022

A model framework for generating the evidence to demonstrate the efficacy of digital therapeutics so they can secure regulatory approval and reimbursement has been published by a trade organisation representing digital health companies. The post Evidence standard drawn up for digital therapeutics appeared first on.

Healthcare 78

Healthcare Healthcare Safety Patients 78

pharmaphorum

JANUARY 11, 2023

BioMarin’s has signed the first contract with an insurer in Germany for Roctavian, its recently approved gene therapy for haemophilia A, as it tests out its outcomes-based agreement (OBA) reimbursement model in the EU.

Insurance 52

Insurance Physicians Patients Marketing 52

Nixon Gwilt Law

JULY 18, 2023

National coverage determinations (NCD) apply to all MACs across the United States and present the best opportunities for consistency in reimbursement. This siloed approach has resulted in a lengthy timeline for when a device may practically expect to enter the market as a covered device eligible for reimbursement.

FDA 52

FDA Manufacturing Food and Drug Administration Marketing 52

Nixon Gwilt Law

SEPTEMBER 7, 2023

On the clinical side, addressing childhood onset conditions early creates significant potential for positive impact well into adulthood. For example, if you are conducting a clinical trial to study your device that requires pediatric participants, the participants’ parents, and sometimes the child, must provide informed consent.

Food and Drug Administration 52

Food and Drug Administration Education Insurance Healthcare 52

Pharmaceutical Technology

FEBRUARY 10, 2023

Partly in response to such drugs, risk-sharing agreements (RSAs) have increased in popularity and aim to mitigate the risks of including high-cost drugs on reimbursement lists and healthcare plans. This is not the first treatment to come with a high price tag. Further breakdowns on RSAs are available within GlobalData’s Risk sharing database.

Marketing 105

Marketing Medicine Leads Safety 105

Nixon Gwilt Law

NOVEMBER 9, 2021

Dentistry is one of a number of clinical specialties that is taking a creative and innovative approach to delivering care using digital health tools. Their reimbursement rates are also higher. If, instead, you plan to contract with payors to reimburse for your tele-dentistry services, it is a bit more complex.

Insurance 52

Insurance Education Leads Training 52

pharmaphorum

DECEMBER 1, 2022

Myeloma Patients Europe (MPE) has identified significant inequalities among patients’ access to myeloma clinical trials in Central and Eastern Europe (CEE) in a first-of-its-kind advocacy report. Of the CEE countries that ran at least one myeloma clinical trial, 11 were EU members.

Patients 72

Patients Physicians Leads 72

Pharmaceutical Technology

JUNE 2, 2023

EDDING is now working towards securing National Reimbursement Drug Listing (NRDL) for Vascepa in China, with plans to launch it commercially by the end of this year. Vascepa has been approved as an adjunct to diet to cut the levels of triglyceride in adult patients suffering from severe hypertriglyceridemia (≥500mg/dL).

Sales 52

Sales Patients Medical 52

Nixon Gwilt Law

JULY 8, 2022

Despite a slight reduction in reimbursement amounts across the board, the rule includes new reimbursement opportunities for managing the care of behavioral health and chronic pain patients, along with much-needed fixes to the Remote Therapeutic Monitoring (“RTM”) codes introduced last year.

Physicians 52

Physicians Management Patients Medical 52

Clarify Health

AUGUST 28, 2023

However, healthcare claims processing as the primary vehicle for reimbursement has been a sticking point for value-based transformation. Increasing reimbursement accuracy and efficiency Healthcare payers recognize the profound impact of accurate and comprehensive healthcare data in refining the claims adjudication process.

Healthcare 52

Healthcare Healthcare Management Patients 52

PM360

FEBRUARY 1, 2024

Key stumbling blocks include payer activation and reimbursement hurdles, regulatory complexities, tepid market adoption by healthcare professionals (HCPs), field force inefficiencies, and obstacles in engaging and adopting patients.

Biopharma 59

Biopharma Competition Prescription Education 59

Pharmaceutical Technology

AUGUST 9, 2022

In the clinical development programme, 1,944 epilepsy patients received cenobamate treatment. Paladin Labs is committed to working collaboratively with regulatory, pricing and reimbursement authorities in order to provide cenobamate to appropriate patients as quickly as possible.”.

Safety 98

Safety Management Patients Pharmaceutical 98

Pharmaceutical Technology

JULY 21, 2022

Currently, the drug combination is offered for preventive usage and the federal government reimburses it. According to data from the PROVENT clinical trial, AZD7442 demonstrated a statistically significant decline in symptomatic Covid-19 development risk. It also showed 83% efficacy compared to a placebo in a six-month assessment.

Government 105

Government Patients Medical Pharmaceutical 105

pharmaphorum

SEPTEMBER 30, 2022

First and most obviously is the detailed data from the Clarity AD study reported this week, which will be revealed at the Clinical Trials on Alzheimer’s Congress (CTAD) in November. If approved, cost and reimbursement will be the next big challenges. point advantage. It also set a benchmark for efficacy as a 0.5

Doctors 52

Doctors Side effects Safety Sales 52

pharmaphorum

NOVEMBER 11, 2022

Several decisions are made in the early stages of clinical development that have key implications for entering markets successfully. Instead, the evidence package must translate this into clear clinical outcomes. A complex matrix of stakeholders.

Marketing 52

Marketing Healthcare Healthcare Networking 52

Pharmaceutical Technology

FEBRUARY 10, 2023

4D Molecular Therapeutics (4DMT), the California-based biotechnology company focused on developing gene therapies for rare and large market diseases, has had the FDA place a clinical hold onto its Fabry disease (FD) gene therapy program (4D-310).

FDA 105

FDA Competition Leads Marketing 105

Clarify Health

OCTOBER 12, 2023

Using their vast datasets , health plans can also help develop evidence-based clinical guidelines and best practices to support providers moving toward value. Many payers are adapting their reimbursement policies to support lower-cost services such as telehealth.

Healthcare Provider 59

Healthcare Provider Insurance Healthcare Healthcare 59

pharmaphorum

JANUARY 20, 2023

Eli Lilly has been unable to secure an accelerated FDA approval for its anti-amyloid Alzheimer’s disease therapy donanemab based on mid-stage clinical results, but says it remains on track to file a traditional submission around the middle of this year.

FDA 64

FDA Safety Side effects Marketing 64

Pharmaceutical Technology

MARCH 14, 2023

It covers cross-functional services through an omnichannel marketing approach designed for the management of the pre-commercial support during the Phase III clinical trials as well as the nationwide commercialisation of CTx-1301.

Food and Drug Administration 59

Food and Drug Administration Medical FDA Marketing 59

World of DTC Marketing

MARCH 29, 2022

The clinical trial proved that a half-hour of walking or other low-intensity activities daily, combined with a low-fat diet, reduced the risk of developing type 2 diabetes by 58 percent. Insurers need to work with companies to develop ways to improve employee wellness, like on-site education on diet and reimbursement for gym memberships.

Insurance 231

Insurance Education Healthcare Healthcare 231

PM360

JUNE 6, 2023

The transaction will create a broad, integrated offering of pharmacy workflow software with patient engagement and clinical solutions to serve the patient, pharmacy, payer, and pharmaceutical company ecosystem, including one of the nation’s largest networks of 40,000 retail, chain, and grocery pharmacies.

Retail 52

Retail Management Pharmaceutical Patients 52